Stachybotrin C and parvisporin, novel neuritogenic compounds, were isolated from the culture broth of Stachybotrys parvispora F4708. Stachybotrin C induced significant neurite outgrowth in PC12 cells and showed cell survival activity in the primary culture of cerebral cortical neurons.
Nerve growth factor (NGF), a polypeptide originally purified from mouse submaxillary gland, is the first and best characterized molecule to support the growth, differentiation and survival of neurons in vitro1'2\
Survival and growth of cultured neuronal cells are also affected by such biological polypeptides as fibroblast growth factor. Epidemal growth factor, insulin and insulin-like growth factors are also known to target non-neuronal cells. These neurotrophic factors have been shownto protect against neuronal dysfunction and death in vivo in animal models of injury and neurologic disease.
For example, NGFtreatment was found to prevent the lesion-induced loss of septal cholinergic neurons in rats3'4) and to reduce the occurrence of hippocampal delayed neuronal death following transient ischemia in Mongolian gerbils5).
It was also reported that basic fibroblast growth factor (bFGF) prevents retrograde degeneration of thalamic neurons after cortical infarction in rats6). These observations rationalize the idea that low molecular compounds exhibiting neurotrophic 635 actions can be developed as promising therapeutic drugs to prevent neuronal cell death occuring after cerebral hemorrhage caused by ischemia, and to ameliorate some types of dementia. It is well known that the PC12 cell line, a rat pheochromocytoma, responds to NGF and bFGF by differentiating into neuron-like cells with elongated outgrowthlf2*7). In the present study, we have utilized, this property of PC12 cell line in the purification of novel neurotrophic compounds stachybotrin C and parvisporin from the culture broth of a Stachybotrys parvispora F4708. We have furthermore examined the effect of stachybotrin C and parvisporin on cell death in cultured rat cortical neurons by treatment with or without in vitro hypoxia. This paper describes the taxonomy of the producing strain, fermentation, isolation, physico-chemical properties and biological activities of stachybotrin C and parvisporin. 
Materials and Methods

Taxonomic Studies
Neuronal Cell Preparation and Cell Survival Assay
The primary culture of cerebral cortical neurons was prepared from 18-day-old Wistar rat embryos. Dissociated neuronal cells in a 1 : 1 mixture of DMEM and
Ham's F12 medium containing with 10% heat-inac- AUG. 1997 tivated FBS, lOO U/ml penicillin, and 100 /xg/ml streptomycin (DF-FBS medium) were plated on 24-well plates coated with polyethylenimine9) at 1 x 105 cells/cm2 and incubated at 37°C in a humidified 5% CO2 incubator (day 0). On day 1, the mediumwas changed to a serumfree DF medium supplemented with 5 /xg/ml transferin, 5fig/ml insulin, and 20fiM progesterone (DF-TIP medium) in the presence of a test compoundand further incubated for 5 days. On day 4, hypoxic stress was given by incubating the culture for 4 hours in a humidified atmosphere of 1% O2-5% CO2 in N2, and these cells were cultured for a further 48 hours in 5% CO2 in air.
The effect of a test compoundon the neuronal cells was evaluated by the activities of neuronal survival and neurite extention. Viable cells were measured by the MTT colorimetric method10).
The neurite extention was monitored under a phasecontrast microscope in comparison with that of the control cells.
Results
Taxonomyof the Producing Strain
For the cultural characterization, strain F4708 was incubated for 14 days at 26°C using three agar media described below. Colonies on potato glucose agar grew moderately, attaining a diameter of 36-39mm and were felty, dark yellowish gray in color. The reverse side of colonies was deep reddish yellow, and pale reddish yellow at the margin. Pale orange soluble pigments were produced into the agar. Colonies on oatmeal agar grew also moderately, attaining a diameter of 37-39mm. They were felty to veltinouse, and very dark yellowish green in color. The rerverse side of colonies was pale yellow. No soluble pigment was observed, but clear exudate was abundantly present on the surface of agar. Colonies on malt extract agar grew rather slowly, attaining a diameter of 15-17mm. They were felty and light greyish orange, and their reverse side was dull orange. Morphological observations were made on the culture grown at 26°C on potato glucose agar. The scanning electron micrograph of Stacybotrys parvispora F4708 is shown in Fig. 2a . Conidiogenous cells were monophialidic.
Conidiophores arose from aerial hypae or hyphal ropes, and mostly simple but sometime branched and were covered with granules. They were hyaline in color and smooth-walled, up to 83jLtm long, and 2.9-4.8[im thick at the base, tapering to 1.7-2.9/mi.
Phialides were clavate, 6.7-ll.4/mi long, and 2.9-4.8 m thick in the broadest part. Conidia were aggregated, unicellular, dark greyish green, ellipsoidal and 3.8~5.9 x 2.7~2.9fim in size. The surface of conidia was smooth by a microscope, but a minutely roughened-wall was observed by a Scanning electron microscope (Fig. 2b) 
Isolation
Isolation of stachybotrin C and parvisporin are outlined in Fig. 3 . Activity was monitored by the neurite outgrowth assay using PC12 cells. The active compoundfirst eluted was further purified by preparative HPLC(column: Senshu-Pak ODS-4251-N, 10 i.d.x250mm) using 60% CH3CN to give stachybotrin C (9.2mg). The second active compound was subjected to preparative HPLCand eluted with 55% CH3CNto yield parvisporin (3.7mg). . AUG. 1997 Physico-chemical Properties Stachybotrin C and parvisporin were isolated as yellowish white powders. They are readily soluble in methanol, ethanol and acetone, slightly soluble in hexane and benzene and practically insoluble in water. They give positive color reactions to iodine, sulfuric acid, FeCl3 but negative to ninhydrin.
The physico-chemical properties of stachybotrin C and parvisporin are summarized in Table 1 . The IR and UV spectra of stachybotrin C are clearly different from those of parvisporin. Their molecular formulae are established to be C31H39NO5for stachybotrin C and C23H34O5 for parvisporin, respectively, by their molecular ion (M+) measurements in their HREIMS. Their *H NMRspectra are shown in Fig. 4 and 5 respectively. The structures of stachybotrin C and parvisporin are determined as shown in Fig. 1 by the extensive analyses of their NMRspectra and chemical derivatization. The details will be described in the succeeding paper13).
Biological Properties
Stachybotrin C and parvisporin generated neurite outgrowth PC12 as shown in Fig. 6 . Stachybotrin C induced a significant neurite outgrowth at a dose of 30/ig/ml, corresponding to NGF at 50ng/ml. Neurite induction activity of parvisporin was substantially weaker than that of stachybotrin C.
Cell survival activity of Stachybotrin C and parvisporin was examined using rat cortical neuronal cells. As shown in Table 2 , stachybotrin C showed marked protective effects against neuronal cell damages. The maximal effect was observed at 3 /^g/ml, and viable cells increased 7 fold in comparison with those of the control. This cell survival activity was also observed after a hypoxic stress condition, and the index of living neurons was almost the same as that in non-hypoxic condition. Furthermore, stachybotrin C generated neurite outgrowth in the primary neuronal culture (data not shown). Parvisporin showed no cell survival activity.
Discussion
Several neuritogenic compounds such as lactacystin14), BU-4514N15), PS-99016), nerfilin I17) and epolactaene18), have been isolated so far from various microbial sources. Stachybotrin C is the first example of microbial metabolite which showeda protective effect in an in vitro anoxia model using a primary culture ofcortical neurons.
Since its protective effect on neuronal cell damage is pronounced,stachybotrin C is supposedto workas a neurotrophic factor in cerebral neurons, and is expected to prevent hypoxic neuronal injury caused by ischemia.
Evaluation of stachybotrin C against a variety of experimental cerebral hypoxia and models of ischemia is underway. 
